Myasthenia gravis in children: Long-term follow-up

M. Rodriguez, M. R. Gomez, F. M. Howard, W. F. Taylor

Research output: Contribution to journalArticle

131 Citations (Scopus)

Abstract

We report observations made on 149 patients with juvenile myasthenia gravis studied from onset of disease for as long as 40 years. Median follow-up was 17 years; minimum was 4 years. Eight other patients with congenital myasthenia gravis were studied separately. Of the juvenile myasthenic patients, 85 (57%) underwent thymectomy because of disease severity. In juvenile myasthenia gravis, a spontaneous remission rate of 22.4 per 1,000 person-years was observed, regardless of disease duration. A remission rate of 260 per 1,000 person-years was seen during the first year after thymectomy, with a rate of 95 per 1,000 person-years during the next 2 years. Early surgery, presence of bulbar symptoms, absence of ocular signs or generalized symptoms, onset of symptoms between ages 12 and 16, and presence of other immune disease were associated with increased postoperative remission rates. Epilepsy (4 patients) and neoplasia (7 patients) were the most frequent associated nonimmune disorders; rheumatoid arthritis (5 patients), juvenile-onset diabetes mellitus (3 patients), asthma (3 patients), and thyroid disease (3 patients) were the most frequent associated immune diseases.

Original languageEnglish (US)
Pages (from-to)504-510
Number of pages7
JournalAnnals of Neurology
Volume13
Issue number5
StatePublished - 1983

Fingerprint

Myasthenia Gravis
Thymectomy
Immune System Diseases
Congenital Myasthenic Syndromes
Spontaneous Remission
Thyroid Diseases
Muscle Weakness
Type 1 Diabetes Mellitus
Epilepsy
Rheumatoid Arthritis
Asthma

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Rodriguez, M., Gomez, M. R., Howard, F. M., & Taylor, W. F. (1983). Myasthenia gravis in children: Long-term follow-up. Annals of Neurology, 13(5), 504-510.

Myasthenia gravis in children : Long-term follow-up. / Rodriguez, M.; Gomez, M. R.; Howard, F. M.; Taylor, W. F.

In: Annals of Neurology, Vol. 13, No. 5, 1983, p. 504-510.

Research output: Contribution to journalArticle

Rodriguez, M, Gomez, MR, Howard, FM & Taylor, WF 1983, 'Myasthenia gravis in children: Long-term follow-up', Annals of Neurology, vol. 13, no. 5, pp. 504-510.
Rodriguez M, Gomez MR, Howard FM, Taylor WF. Myasthenia gravis in children: Long-term follow-up. Annals of Neurology. 1983;13(5):504-510.
Rodriguez, M. ; Gomez, M. R. ; Howard, F. M. ; Taylor, W. F. / Myasthenia gravis in children : Long-term follow-up. In: Annals of Neurology. 1983 ; Vol. 13, No. 5. pp. 504-510.
@article{e9ffb18fbbe94952853811f21b04e8b4,
title = "Myasthenia gravis in children: Long-term follow-up",
abstract = "We report observations made on 149 patients with juvenile myasthenia gravis studied from onset of disease for as long as 40 years. Median follow-up was 17 years; minimum was 4 years. Eight other patients with congenital myasthenia gravis were studied separately. Of the juvenile myasthenic patients, 85 (57{\%}) underwent thymectomy because of disease severity. In juvenile myasthenia gravis, a spontaneous remission rate of 22.4 per 1,000 person-years was observed, regardless of disease duration. A remission rate of 260 per 1,000 person-years was seen during the first year after thymectomy, with a rate of 95 per 1,000 person-years during the next 2 years. Early surgery, presence of bulbar symptoms, absence of ocular signs or generalized symptoms, onset of symptoms between ages 12 and 16, and presence of other immune disease were associated with increased postoperative remission rates. Epilepsy (4 patients) and neoplasia (7 patients) were the most frequent associated nonimmune disorders; rheumatoid arthritis (5 patients), juvenile-onset diabetes mellitus (3 patients), asthma (3 patients), and thyroid disease (3 patients) were the most frequent associated immune diseases.",
author = "M. Rodriguez and Gomez, {M. R.} and Howard, {F. M.} and Taylor, {W. F.}",
year = "1983",
language = "English (US)",
volume = "13",
pages = "504--510",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Myasthenia gravis in children

T2 - Long-term follow-up

AU - Rodriguez, M.

AU - Gomez, M. R.

AU - Howard, F. M.

AU - Taylor, W. F.

PY - 1983

Y1 - 1983

N2 - We report observations made on 149 patients with juvenile myasthenia gravis studied from onset of disease for as long as 40 years. Median follow-up was 17 years; minimum was 4 years. Eight other patients with congenital myasthenia gravis were studied separately. Of the juvenile myasthenic patients, 85 (57%) underwent thymectomy because of disease severity. In juvenile myasthenia gravis, a spontaneous remission rate of 22.4 per 1,000 person-years was observed, regardless of disease duration. A remission rate of 260 per 1,000 person-years was seen during the first year after thymectomy, with a rate of 95 per 1,000 person-years during the next 2 years. Early surgery, presence of bulbar symptoms, absence of ocular signs or generalized symptoms, onset of symptoms between ages 12 and 16, and presence of other immune disease were associated with increased postoperative remission rates. Epilepsy (4 patients) and neoplasia (7 patients) were the most frequent associated nonimmune disorders; rheumatoid arthritis (5 patients), juvenile-onset diabetes mellitus (3 patients), asthma (3 patients), and thyroid disease (3 patients) were the most frequent associated immune diseases.

AB - We report observations made on 149 patients with juvenile myasthenia gravis studied from onset of disease for as long as 40 years. Median follow-up was 17 years; minimum was 4 years. Eight other patients with congenital myasthenia gravis were studied separately. Of the juvenile myasthenic patients, 85 (57%) underwent thymectomy because of disease severity. In juvenile myasthenia gravis, a spontaneous remission rate of 22.4 per 1,000 person-years was observed, regardless of disease duration. A remission rate of 260 per 1,000 person-years was seen during the first year after thymectomy, with a rate of 95 per 1,000 person-years during the next 2 years. Early surgery, presence of bulbar symptoms, absence of ocular signs or generalized symptoms, onset of symptoms between ages 12 and 16, and presence of other immune disease were associated with increased postoperative remission rates. Epilepsy (4 patients) and neoplasia (7 patients) were the most frequent associated nonimmune disorders; rheumatoid arthritis (5 patients), juvenile-onset diabetes mellitus (3 patients), asthma (3 patients), and thyroid disease (3 patients) were the most frequent associated immune diseases.

UR - http://www.scopus.com/inward/record.url?scp=0020558103&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020558103&partnerID=8YFLogxK

M3 - Article

C2 - 6870202

AN - SCOPUS:0020558103

VL - 13

SP - 504

EP - 510

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 5

ER -